MedPath

Investigation of the Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis

Not Applicable
Completed
Conditions
Multiple Sclerosis
Interventions
Other: Motor Imagery training
Other: Action Observation training
Other: standard rehabilitation
Registration Number
NCT05377476
Lead Sponsor
Hacettepe University
Brief Summary

It was planned to examine the effects of motor imagery and action observation applied in addition to standard rehabilitation in individuals with Multiple Sclerosis on walking, fatigue, and muscle oxygenation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Being between the ages of 18-65
  • A definitive diagnosis of MS by a neurologist according to the 2017 McDonald Criteria
  • Expanded Disability Status Scale (EDSS) score of 4.0 and below (it is determined routinely by the physician during the examination)
  • Not having an attack in the last 3 months
  • A minimum score of 4 in each motor imagery ability (internal visual imagery, external visual imagery, and kinesthetic imagery) on the Movement Imagery Questionnaire-3 (MIQ-3)
Exclusion Criteria
  • cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score of less than 24
  • Having another musculoskeletal, cardiovascular, pulmonary, metabolic, or neurological disease severe enough to preclude participation in the study.
  • Having severe vision and hearing problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Motor Imagery GroupMotor Imagery trainingIndividuals included in this group will receive 20 minutes of motor imagery training in addition to 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.
Action Observation GroupAction Observation trainingIndividuals included in this group will receive 20 minutes of action observation training in addition to 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.
Action Observation Groupstandard rehabilitationIndividuals included in this group will receive 20 minutes of action observation training in addition to 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.
Control Groupstandard rehabilitationIndividuals included in this group will receive only 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.
Motor Imagery Groupstandard rehabilitationIndividuals included in this group will receive 20 minutes of motor imagery training in addition to 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.
Primary Outcome Measures
NameTimeMethod
6 Min Walking Test6 week

It will be used to measure walking distance. Before the test is administered, individuals will be given the necessary information and will be asked to walk as fast as possible on a 30-meter track for 6 minutes.

Secondary Outcome Measures
NameTimeMethod
Timed Up and Go Test6 week

It will be used to evaluate the dynamic balance of individuals while walking. Individuals will be asked to stand up from the chair they are sitting on without support and walk a distance of 3 meters, then return from the designated area and sit on the chair without support.

Multiple Sclerosis Walking Scale-126 week

It is a scale used to measure perceived walking ability.

RehaGait® (Hasomed, Magdeburg, Germany) Gait Analysis6 week

The device gives about the time-distance characteristics and kinematic data of the gait.

Fatigue Severity Scale6 week

It is a scale that evaluates the extent to which fatigue affects the daily functions of MS patients. The lowest score that can be obtained from the scale is 7, while the highest score is 63. It is accepted that the severity of fatigue increases as the total score increases.

Measurement of Muscle Oxygenation6 week

It will be measured over the Quadriceps muscle with the MOXY Monitor Device. The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near infrared spectroscopy (NIRS).

Trial Locations

Locations (1)

Hacettepe University

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath